Create Free Account

By creating account you will get access to hot stocks & personalised emails

HeraMED Ltd

Healthcare AU HMD

0.019AUD
0.001(5.56%)

Last update at 2024-07-25T05:29:00Z

Day Range

0.020.02
LowHigh

52 Week Range

0.010.08
LowHigh

Fundamentals

  • Previous Close 0.02
  • Market Cap12.03M
  • Volume50000
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-4.38113M
  • Revenue TTM0.40M
  • Revenue Per Share TTM0.002
  • Gross Profit TTM 0.14M
  • Diluted EPS TTM-0.03

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -4.88066M -5.70894M -3.35897M -3.24704M -3.76648M
Minority interest - - - - -
Net income -6.61857M -7.38291M -3.45822M -3.32376M -3.76648M
Selling general administrative 1.71M 1.73M 1.16M 1.24M 1.81M
Selling and marketing expenses 0.50M 0.46M 0.86M 0.98M 0.32M
Gross profit 0.14M 0.04M 0.00793M 0.03M -0.05690M
Reconciled depreciation 0.36M 0.27M 0.34M 0.35M 0.30M
Ebit -3.14275M -3.93894M -3.34864M -3.23959M -2.87490M
Ebitda -2.78434M -3.66724M -3.08997M -2.99670M -2.57974M
Depreciation and amortization 0.36M 0.27M 0.26M 0.24M 0.30M
Non operating income net other - - - - -
Operating income -3.14275M -3.93894M -3.34864M -3.23959M -2.87490M
Other operating expenses 3.40M 4.03M 3.49M 3.49M 2.95M
Interest expense 1.74M 1.67M 0.01M 0.00745M 0.89M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.04M 1.67M 0.00312M 0.03M 0.04M
Net interest income -1.69978M -1.67389M 0.00405M 0.04M -1.26322M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1.74M 1.67M 0.10M 0.08M 0.00000M
Total revenue 0.22M 0.09M 0.04M 0.15M 0.08M
Total operating expenses 3.32M 3.98M 3.46M 3.38M 2.82M
Cost of revenue 0.08M 0.04M 0.03M 0.11M 0.13M
Total other income expense net -1.73791M -1.77001M -0.01033M -0.00745M -0.89158M
Discontinued operations - - - - -
Net income from continuing ops -4.88066M -5.70894M -4.36116M -4.46601M -5.33647M
Net income applicable to common shares -4.88066M -5.70894M -3.35897M -3.12888M -3.76648M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 2.95M 4.16M 4.59M 3.19M 3.60M
Intangible assets - 1.04M 0.67M 0.97M 1.16M
Earning assets - - - - -
Other current assets - - 0.04M 0.10M 0.12M
Total liab 2.27M 1.30M 4.70M 1.20M 1.22M
Total stockholder equity 0.68M 2.86M -0.10598M 2.00M 2.39M
Deferred long term liab - 1.04M 0.67M 0.87M 1.06M
Other current liab 0.05M 0.05M 0.03M 0.01M 0.02M
Common stock 35.33M 22.16M 16.48M 13.38M 10.79M
Capital stock - 22.16M 16.48M 13.38M 10.79M
Retained earnings -42.12226M -24.23935M -19.35869M -13.64975M -10.40894M
Other liab - 0.50M 0.55M 0.49M 0.50M
Good will - - - - -
Other assets 0.00000M 1.04M 0.67M 0.87M 1.06M
Cash 1.06M 2.62M 3.56M 1.90M 2.05M
Cash and equivalents - - - - -
Total current liabilities 1.51M 0.79M 4.15M 0.52M 0.54M
Current deferred revenue 0.00000M - - - -
Net debt -0.79935M -2.43849M -0.14091M -1.71230M -1.80453M
Short term debt 0.26M 0.18M 3.42M 0.00581M 0.07M
Short long term debt - 0.18M 3.42M - -
Short long term debt total 0.26M 0.18M 3.42M 0.19M 0.24M
Other stockholder equity 0.00000M 0.09M 2.77M 2.27M 0.12M
Property plant equipment - 0.08M 0.03M 0.02M 0.09M
Total current assets 1.93M 3.04M 3.89M 2.21M 2.36M
Long term investments - - - - -
Net tangible assets - 2.86M -0.77634M 1.90M 2.29M
Short term investments - 0.02M 0.03M - -
Net receivables 0.50M 0.25M 0.24M 0.23M 0.14M
Long term debt - - 0.00000M 0.19M 0.17M
Inventory 0.36M 0.17M 0.09M 0.07M 0.06M
Accounts payable 1.20M 0.56M 0.69M 0.50M 0.46M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 7.47M 4.94M 2.77M 2.27M 1.89M
Additional paid in capital - - - - -
Common stock total equity - - - 17.37M 15.40M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.95M - 0.00000M 0.00000M 0.00000M
Deferred long term asset charges - - - - -
Non current assets total 1.03M 1.11M 0.70M 0.99M 1.25M
Capital lease obligations - - - 0.00754M 0.10M
Long term debt total - 0.00000M 0.00000M 0.19M 0.17M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.69078M -0.08543M -0.07588M -0.29578M -0.24606M
Change to liabilities 0.00000M 0.19M 0.04M -0.01418M 0.04M
Total cashflows from investing activities -0.69078M -0.08543M -0.06731M -0.20722M -0.17367M
Net borrowings -0.10290M 1.69M -0.10534M -0.08128M 1.48M
Total cash from financing activities 2.54M 4.88M 2.52M 0.82M 8.45M
Change to operating activities - - - 0.05M 0.01M
Net income -6.61857M -5.70894M -3.35897M -3.12888M -3.76648M
Change in cash -0.94238M 1.66M -0.14166M -1.98822M 5.65M
Begin period cash flow 3.56M 1.90M 2.05M 4.03M 0.06M
End period cash flow 2.62M 3.56M 1.90M 2.05M 5.72M
Total cash from operating activities -6.26016M -3.23179M -2.78807M -2.72687M -1.76615M
Issuance of capital stock 2.64M 3.31M 2.62M 0.92M 4.49M
Depreciation 0.36M 0.27M 0.34M 0.35M 0.30M
Other cashflows from investing activities - - - - 0.00427M
Dividends paid - - - - -
Change to inventory - -0.01922M -0.01118M 0.05M -0.04174M
Change to account receivables - -0.00840M 0.02M -0.07742M -0.16239M
Sale purchase of stock 2.64M 3.31M 2.62M 0.92M 4.49M
Other cashflows from financing activities -0.10290M 1.69M -0.10534M -0.09222M 2.31M
Change to netincome - 2.21M 0.27M 0.28M 1.94M
Capital expenditures 0.69M 0.09M 0.06M 0.21M 0.00716M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.02M 0.00048M 0.00594M 0.01M 0.00088M
Stock based compensation - - - - -
Other non cash items 6.26M 5.44M 3.02M 2.78M 3.47M
Free cash flow -6.95094M -3.31721M -2.84651M -2.93409M -2.50949M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
HMD
HeraMED Ltd		 0.001 5.56% 0.02 - - 14.91 8.62 13.26 -1.3453
COH
Cochlear Ltd		 14.07 4.19% 349.65 62.84 46.30 9.75 11.76 9.62 36.63
PNV
Polynovo Ltd		 0.06 2.15% 2.62 - 140.85 17.37 21.49 17.51 647.42
AVH
Avita Therapeutics Inc		 0.13 4.33% 3.13 - - 8.59 5.71 6.72 -10.0538
EBR
Ebr Systems Inc CDR		 0.01 0.93% 1.09 - - - 5.68 - -7.482

Reports Covered

Stock Research & News

View All

Profile

HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. It also provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a cloud-based remote maternity care platform. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is based in Netanya, Israel.

HeraMED Ltd

4 Hazoran Street, Netanya, Israel, 4250604

Key Executives

Name Title Year Born
Mr. David Groberman Co-Founder, CEO & Exec. Director NA
Mr. Tal Slonim Co-Founder, COO & Exec. Director NA
Ms. Sivan Sadan Chief Financial Officer NA
Mr. Michael Nenner Chief Technology Officer NA
Henry Jordan Head of Investor Relations NA
Mr. Ariel Laden VP of Marketing NA
Dr. Josef Tovbin Chief Medical Officer NA
Mr. Jonathan Hart B.Com., L.L.B. Company Sec. NA
Dr. Ronald Peter Weinberger AIMM, BSc (Hons), Ph.D. Executive Chairman NA
Dr. Ronald Peter Weinberger AIMM, BSc (Hons), Ph.D. Executive Chairman NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.